Notice NOT-HD-21-051 from the NIH Guide for Grants and Contracts

Notice NOT-GM-22-001 from the NIH Guide for Grants and Contracts

Notice NOT-AI-22-004 from the NIH Guide for Grants and Contracts

Notice NOT-DC-22-001 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-22-071 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA), entitled "Toward Translation of Nanotechnology Cancer Interventions" (TTNCI), encourages applications for advanced pre-clinical research, supporting translation of nanotechnology-based cancer diagnostics and therapeutics. TTNCI awards are designed to mature experimental nanomedicines relying on nanoparticles and nano-devices which demonstrate strong potential to improve cancer treatment effectiveness due to the combination of nanoparticle/nano-device structural design and/or therapeutic/diagnostic cargo which is delivered. TTNCI awards are expected to enable further development of proposed nanotechnology-based interventions to the stage in which they could continue on a developmental path towards the NCI Experimental Therapeutics (NExT) and other NCI translational programs.

Funding Opportunity PAR-22-072 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research that will advance the measurement and assessment of complex constructs relevant to minority health and health disparities.

Experience with bioinformatic tools for the analysis of large-scale molecular datasets. Prepare and submit scientific manuscripts. $52,000 a year
From University of Wyoming - Sat, 20 Nov 2021 02:16:00 GMT - View all Laramie, WY jobs

£70,000 - £75,000 depending on experience, plus benefits: Singular Talent: Take ownership over data functions in a brand new drug discovery field - work in the way you want and be the data expert... Oxfordshire (GB)

Competitive Salary: F. Hoffmann-La Roche AG: At Roche, we believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about tran Switzerland (CH)

Competitive Salary: F. Hoffmann-La Roche AG: At Roche, we believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about tran Switzerland (CH)

Notice NOT-NR-22-006 from the NIH Guide for Grants and Contracts

Notice NOT-NR-22-005 from the NIH Guide for Grants and Contracts

Notice NOT-GM-22-004 from the NIH Guide for Grants and Contracts

Notice NOT-MH-22-040 from the NIH Guide for Grants and Contracts

Notice NOT-DA-22-047 from the NIH Guide for Grants and Contracts

Notice NOT-DE-21-015 from the NIH Guide for Grants and Contracts

Notice NOT-HS-22-009 from the NIH Guide for Grants and Contracts

Notice NOT-MH-22-055 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-22-073 from the NIH Guide for Grants and Contracts. Through this I-Corps at NIH program Funding Opportunity Announcement (FOA), NIH and CDC provide administrative supplement awards to active SBIR (NIH and CDC) and STTR Phase I (NIH only) grantees/awardees. The I-Corps at NIH mission is to empower entrepreneurs in developing and validating a strategic business model through diverse customer discovery in order to meet unmet clinical needs. I-Corps enables and accelerates the transformation of invention to impact SBIR and STTR Phase I awardees in a no-cost extension are eligible as long as, if selected, their no cost extension covers the entire duration of I-Corps at NIH cohort. The program provides three-member project teams with access to instruction and mentoring to accelerate the translation of technologies currently being developed with NIH and CDC SBIR and STTR funding. It is anticipated that outcomes for the I-Corps teams participating in this program will include significantly refined commercialization plans and well-informed pivots in their overall commercialization strategies. Prospective applicants are strongly encouraged to contact Scientific/Research staff for more information about the program before applying.

Funding Opportunity PAR-22-067 from the NIH Guide for Grants and Contracts. Reissue of PAR-19-028 This Funding Opportunity Announcement (FOA) solicits research projects focused on the dynamic and mechanistic links between the maturation of brain circuits and behaviors across development in rodents and non-human primates. The goal is to build a foundation for understanding how interactions within and among brain regions change over pre- and post-natal development, allowing for the emergence of cognitive, affective and social behaviors. To this end, projects supported will focus on neurodevelopmental trajectories in rodents or non-human primates and investigate questions using in vivo neural measures in awake, behaving animals. This FOA uses the R21 grant mechanism, whereas its companion funding opportunity seeks shorter, higher-risk R01 grant applications.